|
|
定喘汤加减方联合西药疗法对小儿哮喘治疗的Meta分析
|
Abstract:
目的：本研究旨在评估定喘汤加减方联合西药与传统西医治疗在儿童哮喘方面的临床疗效与安全性。方法：通过计算机检索了包括PubMed、Web of Science、CNKI、万方数据库在内的多个文献库，并对所有纳入文献进行质量评估。研究最终纳入了18篇回顾性队列研究，共涉及1622例患者，并运用RevMan5.4.1软件进行Meta分析。结果：Meta分析显示，在主要结局指标——总体干预有效率方面，定喘汤加减方联合西药疗法明显相对于传统西医疗法具有显著优势(OR = 5.90, 95% CI [3.99, 8.71], P < 0.00001)。值得注意的是，治疗后不良反应发生率与定喘汤加减联合西药治疗无关。结论：定喘汤加减方展现出良好的疗效性和安全性，尤其是在改善气道炎症、增加呼吸气流量、减轻哮喘症状方面。这一系统评价为临床医生和患者在选择小儿哮喘疗法时提供了重要的参考依据。
Objective: To evaluate the clinical efficacy and safety of Dingchuan decoction combined with western medicine and traditional western medicine in the treatment of childhood asthma. Methods: Several literature databases including PubMed, Web of Science, CNKI and Wanfang were searched by computer, and the quality of all the included literature was evaluated. A total of 18 retrospective cohort studies involving 1622 patients were included and a Meta-analysis was performed using RevMan5.4.1 software. Results: The Meta-analysis revealed that in terms of the primary outcome indicator, namely the overall intervention effectiveness rate, the combination of modified Dingchuan decoction and western medicine therapy exhibited a significant advantage over traditional western medicine therapy (OR = 5.90, 95% CI [3.99, 8.71], P < 0.00001). It is worth noting that the incidence of adverse reactions after treatment and Dingchuan decoction combined with western medicine treatment was not related. Conclusion: Dingchuan decoction shows good efficacy and safety, especially in improving airway inflammation, increasing respiratory flow and relieving asthma symptoms. This systematic review provides an important reference for clinicians and patients in the selection of pediatric asthma therapy.
| [1] | National Cooperative Group on Childhood Asthma, Institute of Environmental Health and Related Product Safety, Chinese Center for Disease Control and Prevention and Chinese Center for Disease Control and Prevention (2013) Third Nationwide Survey of Childhood Asthma in Urban Areas of China. Chinese Journal of Pediatrics, 51, 729-735. |
| [2] | Huang, K., Yang, T., Xu, J., Yang, L., Zhao, J., Zhang, X., et al. (2019) Prevalence, Risk Factors, and Management of Asthma in China: A National Cross-Sectional Study. The Lancet, 394, 407-418. https://doi.org/10.1016/s0140-6736(19)31147-x |
| [3] | Lee, H., Ryu, J., Nam, E., Chung, S.J., Yeo, Y., Park, D.W., et al. (2019) Increased Mortality in Patients with Corticosteroid-Dependent Asthma: A Nationwide Population-Based Study. European Respiratory Journal, 54, Article 1900804. https://doi.org/10.1183/13993003.00804-2019 |
| [4] | Zhang, Y., Guo, H., Cheng, B.C., Su, T., Fu, X., Li, T., et al. (2018) Dingchuan Tang Essential Oil Inhibits the Production of Inflammatory Mediators via Suppressing the IRAK/Nf-κB, IRAK/AP-1, and TBK1/IRF3 Pathways in Lipopolysaccharide-Stimulated RAW264.7 Cells. Drug Design, Development and Therapy, 12, 2731-2748. https://doi.org/10.2147/dddt.s160645 |
| [5] | Li, X. and Brown, L. (2009) Efficacy and Mechanisms of Action of Traditional Chinese Medicines for Treating Asthma and Allergy. Journal of Allergy and Clinical Immunology, 123, 297-306. https://doi.org/10.1016/j.jaci.2008.12.026 |
| [6] | Xie, B. (2011) Effects of Dingchuan Decoction Combined with Airway Inhalation of Corticosteroids and β. Chinese Journal of Experimental Traditional Medical Formulae, 17, 247-248. |
| [7] | 丁梦恬. 麻龙定喘汤联合雾化治疗小儿哮喘发作期痰热阻肺证的临床疗效观察[D]: [硕士学位论文]. 南京: 南京中医药大学, 2020. |
| [8] | 付芸芸, 尹贵锦, 韩红霞, 等. 抑咳祛痰平喘汤联合孟鲁司特钠治疗脾肺虚弱型小儿哮喘临床观察[J]. 光明中医, 2022, 37(10): 1841-1843. |
| [9] | 全良锦, 李超. 止咳定喘汤联合布地奈德混悬液雾化吸入治疗小儿哮喘发作期热哮证的临床效果[J]. 临床合理用药杂志, 2022, 15(26): 121-123, 130. |
| [10] | 吕登雷. 定喘汤加减联合孟鲁司特钠治疗咳嗽变异性哮喘患儿的疗效及对其肺功能指标的影响分析[J]. 中国现代药物应用, 2021, 15(3): 222-224. |
| [11] | 张天英, 谷继伟, 沈庆明. 定喘汤加减联合孟鲁司特钠治疗小儿咳嗽变异性哮喘的临床研究[J]. 中医药信息, 2017, 34(1): 113-115. |
| [12] | 张晓霞, 关艳楠, 罗艳. 小儿止咳定喘汤配合普米克令舒雾化吸入治疗小儿哮喘发作期热哮证临床观察[J]. 中国中医急症, 2020, 29(4): 692-694. |
| [13] | 李淑芳. 定喘汤联合布地奈德雾化吸入治疗小儿喘息性支气管炎的临床研究[J]. 中国医药科学, 2019, 9(6): 11-14. |
| [14] | 梅玉霞, 刘小敏, 陆振瑜, 等. 定喘汤联合穴位贴敷对小儿咳嗽变异性哮喘患儿血清骨膜素、sST2和CC-16水平的影响[J]. 检验医学与临床, 2022, 19(4): 532-536. |
| [15] | 江南芳. 定喘汤加减联合孟鲁司特钠治疗小儿咳嗽变异性哮喘的临床疗效[J]. 临床合理用药杂志, 2020, 13(25): 96-97. |
| [16] | 沈奕, 郁燕, 丁焘. 定喘汤联合孟鲁司特钠对小儿咳嗽变异性哮喘(风热袭肺证)患儿中医证候积分、呼气高峰流量及血清ECP浓度的影响[J]. 四川中医, 2023, 41(4): 101-104. |
| [17] | 洪正坤, 何新芳. 宣肺通络平喘汤联合特布他林治疗小儿哮喘的临床效果[J]. 中外医学研究, 2021, 19(22): 123-126. |
| [18] | 王彧玥. 加减定喘汤治疗儿童咳嗽变异性哮喘痰热蕴肺证的临床研究[D]: [硕士学位论文]. 南京: 南京中医药大学, 2018. |
| [19] | 田红妮. 小儿止咳定喘汤配合普米克令舒雾化吸入治疗小儿哮喘发作期热哮证临床疗效及安全性观察[J]. 贵州医药, 2021, 45(12): 1962-1963. |
| [20] | 邓穗超. 定喘汤加味治疗小儿喘息性支气管炎外寒内热证的临床研究[D]: [硕士学位论文]. 南宁: 广西中医药大学, 2021. |
| [21] | 黄煜扉, 傅伟, 李维军. 穴位贴敷联合胡氏定喘汤加减治疗小儿急性喘息性支气管炎的疗效观察[J]. 广州中医药大学学报, 2019, 36(11): 1739-1743. |
| [22] | 杨一民, 洪菲萍, 曾谷兰, 等. 加味定喘汤对儿童哮喘临床效果及炎性介质水平的影响[J]. 中国中西医结合杂志, 2020, 40(6): 691-695. |
| [23] | 饶正良. 活血定喘汤联合布地奈德、沙丁胺醇治疗小儿支气管哮喘对患儿诱导痰液嗜酸性粒细胞占比及血清IL-17水平的影响[J]. 四川中医, 2021, 39(9): 90-92. |
| [24] | Liu, F., Yu, J., Bai, L., Xue, Z. and Zhang, X. (2015) Pingchuan Formula Improves Asthma via Restoration of the Th17/Treg Balance in a Mouse Model. BMC Complementary and Alternative Medicine, 15, Article No. 234. https://doi.org/10.1186/s12906-015-0755-8 |
| [25] | Jayaprakasam, B., Yang, N., Wen, M., Wang, R., Goldfarb, J., Sampson, H., et al. (2013) Constituents of the Anti-Asthma Herbal Formula ASHMI™ Synergistically Inhibit IL-4 and IL-5 Secretion by Murine Th2 Memory Cells, and Eotaxin by Human Lung Fibroblasts in vitro. Journal of Integrative Medicine, 11, 195-205. https://doi.org/10.3736/jintegrmed2013029 |
| [26] | 朱子钰, 赵霞, 纪建建, 吴嘉宝, 单祎文, 严花. 呼吸道合胞病毒感染诱导哮喘发病机制及中医药防治进展[J]. 南京中医药大学学报, 2024, 40(8): 855-863. |
| [27] | 张雄飞, 黄娟萍, 李碧云, 等. 中药治疗哮喘作用机制的研究进展[J]. 中国实验方剂学杂志, 2013, 19(15): 344-347. |
| [28] | 张瑾, 高秋静. 定喘汤加减治疗老年急性发作期哮喘临床研究[J]. 中医学报, 2016, 31(12): 1870-1873. |
